Catherine S. Manno

faculty photo
Emeritus Professor CE of Pediatrics
Department: Pediatrics

Contact information
Physician-in-Chief Office
The Children's Hospital of Philadelphia
34th Street and Civic Center Blvd.
Philadelphia, PA 19104
Office: 2155901216
Fax: 2155903050
Education:
A.B.
Duke University, 1974.
M.D.
Hahnemann Medical College, 1978.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Teachey D.T., Manno C.S., Axsom K.M., Andrews C.S., Choi J.K., Greenbraum B.H., McMann J.M., Sullivan K.E., Travis S.F., Grupp S.A.: Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood 105(6): 2443-2448, 2005.

Axsom K.M., Manno C.S.: Treatment of hemophilia with genetic engineering. Transfusion Alternatives in Transfusion Medicine 6(2): 46-54, 2004.

Rheingold S.A., Burnham J.M., Rutstein R., Manno C.S.: HIV infection presenting as severe autoimmune hemolytic anemia with disseminated intravascular coagulation in an infant. J Ped Hematol/Onco. 26(1): 9-12, 2004.

Manno C.S, Chew A.J., Hutchinson S., Larson P.J., Herzog R.W., Arruda V.R., Tai S.J., Ragni M.V., Thompson A., Ozelo M., Couto L.B., Leonard D.G.B., Johnson F.A., McClelland A., Sallan C., Skarsgard E., Flake A.W., Kay M.A., High K.A., Glader B.: AAV mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101: 2963-2972, 2003.

Manno C.S.: The promise of thrid generation recombinant therapy and gene therapy. Semin Hematol 40(suppl 3): 23-28, 2003.

Manno C.S.: Gene therapy for hemophilia. Curr Opin in Hematol 9(6): 511-515, 2002.

Roseff S.D., Luban N.L.C., Manno C.S.: Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42: 1398-1413, 2002.

Kay M.A., Manno C.S., Ragni M.V., Larson P.J., Couto L.B., McClelland A., Glader B., Chew A.J., Tai S., Herzog R.W., Arruda V., Johnson F., Scallan C., Skarsgard E., Flake A.W., High K.A.: Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 24(3): 257-261, 2001.

Manno C.S.: Gene therapy for hemophilia. Biotech Medical. 19: 3, 2001.

Eder A., Manno C.S.: Does red cell T-activation matter? Br J Hematol 114: 25-30, 2001.

back to top
Last updated: 06/23/2008
The Trustees of the University of Pennsylvania